VELLA, VERONICA
 Distribuzione geografica
Continente #
NA - Nord America 4.538
EU - Europa 2.611
AS - Asia 2.193
SA - Sud America 363
AF - Africa 356
Continente sconosciuto - Info sul continente non disponibili 184
OC - Oceania 9
Totale 10.254
Nazione #
US - Stati Uniti d'America 4.369
SG - Singapore 1.076
RU - Federazione Russa 749
IT - Italia 701
CN - Cina 565
BR - Brasile 295
IE - Irlanda 293
VN - Vietnam 211
CI - Costa d'Avorio 210
UA - Ucraina 166
DE - Germania 139
BE - Belgio 107
CA - Canada 107
NL - Olanda 97
FR - Francia 95
GB - Regno Unito 86
SE - Svezia 80
KR - Corea 77
IN - India 68
SN - Senegal 58
NG - Nigeria 40
BD - Bangladesh 36
MX - Messico 28
AR - Argentina 24
IQ - Iraq 21
TR - Turchia 21
JP - Giappone 20
PL - Polonia 18
EC - Ecuador 16
HK - Hong Kong 16
ES - Italia 14
CH - Svizzera 12
FI - Finlandia 12
IR - Iran 11
UZ - Uzbekistan 11
CR - Costa Rica 10
ZA - Sudafrica 10
CZ - Repubblica Ceca 9
MA - Marocco 9
AU - Australia 8
KE - Kenya 8
AE - Emirati Arabi Uniti 7
CL - Cile 7
JM - Giamaica 7
PK - Pakistan 7
VE - Venezuela 7
ID - Indonesia 6
PY - Paraguay 6
SA - Arabia Saudita 6
TN - Tunisia 6
BJ - Benin 5
GR - Grecia 5
CO - Colombia 4
KZ - Kazakistan 4
PH - Filippine 4
RO - Romania 4
AT - Austria 3
AZ - Azerbaigian 3
BB - Barbados 3
EG - Egitto 3
ET - Etiopia 3
EU - Europa 3
IL - Israele 3
MY - Malesia 3
RS - Serbia 3
AL - Albania 2
BG - Bulgaria 2
DK - Danimarca 2
DM - Dominica 2
GE - Georgia 2
GT - Guatemala 2
JO - Giordania 2
KG - Kirghizistan 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
UY - Uruguay 2
AG - Antigua e Barbuda 1
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GA - Gabon 1
HN - Honduras 1
HR - Croazia 1
IM - Isola di Man 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LT - Lituania 1
MD - Moldavia 1
ME - Montenegro 1
MK - Macedonia 1
MN - Mongolia 1
MT - Malta 1
NI - Nicaragua 1
NO - Norvegia 1
Totale 10.062
Città #
Singapore 664
Dallas 520
Santa Clara 495
Chandler 374
Moscow 355
San Jose 341
Chicago 310
Dublin 292
Ashburn 267
Abidjan 210
Jacksonville 160
Civitanova Marche 145
Catania 132
Boardman 123
Los Angeles 120
Hefei 104
Beijing 103
Council Bluffs 92
Lauterbourg 76
Seoul 76
Andover 75
Cambridge 75
Lawrence 75
Grafing 73
Nanjing 71
Rotterdam 64
Dakar 58
Toronto 58
Ho Chi Minh City 57
Wingene 50
Houston 48
New York 45
Quintano 41
Wilmington 41
Hanoi 40
Dong Ket 39
Buffalo 38
Des Moines 38
São Paulo 32
Brussels 31
San Mateo 30
Agrigento 29
The Dalles 26
Columbus 23
Nanchang 21
Paternò 21
Stockholm 21
Abuja 20
Hebei 19
London 19
Munich 19
Palermo 19
Tokyo 19
Orem 18
Atlanta 17
Denver 17
Kochi 17
Lagos 17
Brooklyn 16
Chennai 15
Ottawa 15
Saint Petersburg 15
Seattle 15
Warsaw 15
Bremen 14
Jiaxing 14
Amsterdam 13
Hong Kong 13
Phoenix 13
Tianjin 13
Milan 12
Poplar 12
Redondo Beach 12
Rio de Janeiro 12
Shenyang 12
Boston 11
Changsha 11
Nijmegen 11
San Francisco 11
Frankfurt am Main 10
Manchester 10
Paris 10
Da Nang 9
Izegem 9
Mumbai 9
Rome 9
San José 9
Bari 8
Guangzhou 8
Montreal 8
Pune 8
Ardabil 7
Erbil 7
Gravina di Catania 7
Jinan 7
Johannesburg 7
New Delhi 7
Zhengzhou 7
Belo Horizonte 6
Biên Hòa 6
Totale 6.823
Nome #
Novel mechanisms of tumor promotion by the insulin receptor isoform a in triple-negative breast cancer cells 244
A novel functional crosstalk between DDR1 and the IGF axis and its relevance for breast cancer 203
Activation of the s100a7/rage pathway by igf-1 contributes to angiogenesis in breast cancer 193
Thyroidectomy as Treatment of Choice for Differentiated Thyroid Cancer 182
DDR1 regulates thyroid cancer cell differentiation via IGF-2/IR-A autocrine signaling loop 178
Anaplastic thyroid cancer in sicily: The role of environmental characteristics. 175
IGF2: A Role in Metastasis and Tumor Evasion from Immune Surveillance? 171
Comparative proteomic analysis of insulin receptor isoform A and B signaling 168
BRAF(V600E) mutation and the biology of papillary thyroid cancer 165
RAGE inhibition blunts insulin-induced oncogenic signals in breast cancer 164
Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid 162
Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells 160
Effect of combined epigenetic treatments and ectopic NIS expression on undifferentiated thyroid cancer cells 156
Ddr1 affects metabolic reprogramming in breast cancer cells by cross-talking to the insulin/igf system 152
Thyrospheres From Normal or Malignant Thyroid Tissue Have Different Biological, Functional, and Genetic Features 151
Insulin Receptor Isoform A Modulates Metabolic Reprogramming of Breast Cancer Cells in Response to IGF2 and Insulin Stimulation 149
Editorial: Clinical and molecular epidemiology of thyroid cancer of follicular origin 145
DeltaNp73alpha inhibits PTEN expression in thyroid cancer cells 141
A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer 141
PPAR-γ agonists as antineoplastic agents in cancers with dysregulated IGF axis 141
IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway 140
Novel cross-talk between IGF-IR and DDR1 regulates IGF-IR trafficking, signaling and biological responses 140
Abstract 4612: In breast cancer cells IGF-I induces upregulation of DDR1 by suppressing miR-199a-5p via the PI3K/Akt pathway 136
Comment on “Shiatsu as an Adjuvant Therapy for Depression in Patients With Alzheimer’s Disease: A Pilot Study” 136
Insulin resistance: Any role in the changing epidemiology of thyroid cancer? 134
ROLE OF BRAF(V600) MUTATION IN THE RESISTANCE TO GEFITINIB OF THYROID CANCER CELLS 133
Inflammasome activation as a link between obesity and thyroid disorders: Implications for an integrated clinical management 131
Interleukin-4 stimulates papillary thyroid cancer cell survival: Implications in patients with thyroid cancer and concomitant Graves' disease 131
Influence of Mediterranean Diet on Sexual Function in People with Metabolic Syndrome: A Narrative Review 130
Short-term adverse effects of anticancer drugs in patients with type 2 diabetes 130
DeltaNp73alfa favors thyroid tumor progression by PTEN tumor suppressor downregulation 125
Editorial: Early diagnoses and treatments of uncommon breast cancers 122
Insulin receptor isoforms in physiology and disease: An updated view 121
Microenvironmental Determinants of Breast Cancer Metastasis: Focus on the Crucial Interplay Between Estrogen and Insulin/Insulin-Like Growth Factor Signaling 121
Immunostaining for Met/HGF receptor may be useful to identify malignancies in thyroid lesions classified suspicious at fine-needle aspiration biopsy 116
TAp73α increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation 115
Editorial: Resistance to Endocrine Therapies in Cancer 111
COVID-19 and Diabetes: The Importance of Controlling RAGE 110
The IGF system in thyroid cancer:new concepts 109
Sporadic and Familial Medullary Thyroid Carcinoma: A Retrospective Single Center Study on Presentation and Outcome 108
DeltaNp73alfa increases Akt phosphorylation in thyroid cancer cells: role of PTEN tumor suppressor 108
Insulin/IGF signaling and discoidin domain receptors: An emerging functional connection 108
Onset of Marine-Lenhart syndrome and Graves’ ophthalmopathy in a female patient treated with alemtuzumab for multiple sclerosis 107
Reactivation of p53 mutants by p53 reactivation and induction of massive apoptosis in thyroid cancer cells 104
Recapitulating thyroid cancer histotypes through engineering embryonic stem cells 103
p73 tumor-suppressor activity is impaired in human thyroid cancer 103
The p53-homologue p63 may promote thyroid cancer progression 103
Shiatsu as an adjuvant therapy for depression in patients with Alzheimer's disease: A pilot study 103
The possible role of cancer stem cells in the resistance to kinase inhibitors of advanced thyroid cancer 103
Recent views of heavy metals as possible risk factors and potential preventive and therapeutic agents in prostate cancer 102
Exclusion of c-Abl from the Nucleus Restrains the p73 Tumor Suppression Function 101
Insulin receptor isoforms in cancer 100
Metabolic alterations of thyroid cancer as potential therapeutic targets 100
Insulin receptor mediates the effects of the insulin–like growth factor II in breast cancer: a newly identified autocrine/paracrine loop 99
p53 family proteins in thyroid cancer 98
Effetto del trattamento epigenetico combinato di acido valproico e 5-Azacitidina in un modello di carcinomi della Tiroide poco differenziati 97
Metyrapone restores nocturnal cortisol profile and impaired post-dexamethasone suppression in mild autonomous cortisol secretion due to bilateral adrenal incidentaloma 96
Metformin counteracts stimulatory effects induced by insulin in primary breast cancer cells 94
EXOME WIDE ANALYSIS IN 5 PAPILLARY THYROID CARCINOMAS 93
Editorial: A year in review: discussions in cancer endocrinology 92
Il BRAF (V600E) è responsabile della resistenza delle cellule di carcinoma tiroideo al gefinitib. 92
INVOLVEMENT OF THE P53 HOMOLOGOUS P73 IN THYROID CANCER PROGRESSION 92
Type 3 deiodinase: Role in cancer growth, stemness, and metabolism 92
Role of BRAF(V600) mutation in the resistance to gefinitib of thyroid cancer cells. 91
GENOME WIDE ANALYSIS IN PAPILLARY THYROID CARCINOMA 91
Tyrosine kinase inhibitor STI571 enhances thyroid cancer cell motile response to Hepatocyte Growth Factor 91
Thyroid cancer cell resistance to gefinitib depends on the constitutive oncogenic activation of the ERK pahway 91
Insulin-like growth factor II binds to and activate the insulin receptor isoform A in human fetal and cancer cells 90
Long-acting insulin analogs and cancer 89
The emerging role of insulin receptor isoforms in thyroid cancer: Clinical implications and new perspectives 89
TAp63alfa antagonizes p53 oncosuppressor function in thyroid cancer cells 87
Thyrospheres: a new in vitro model for testing human thyroid endocrine disruptors 87
Tap73alfa Increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of mdm2-mediated degradation 84
The insulin receptor isoform-A is a high affinity IGF-II receptor in human fetal cells 83
Insulin/IGF axis and the Receptor for Advanced Glycation End Products: role in meta-inflammation and potential in cancer therapy 81
Thyrospheres an in vitro model for human thyroid carcinogenesis 81
Insulin/IGF-I hybrid receptors play a major role in IGF-I signaling in thyroid cancer 79
The expression of PTEN tumor suppressor is down regulated by the dominant negative p73 isoform ΔNp73 in thyroid cancer cells 76
IFN-I signaling in cancer: the connection with dysregulated Insulin/IGF axis 74
Manuale di endocrinologia geriatrica 74
Short-term adverse affects of anticancer drugs in type 2 diabetes patients. 72
Insulin-like growth factor II stimulates cell growth through the insulin receptor in brest cancer: a newly identified autocrine/paracrine loop 72
EGFR INHIBITION ENHANCES THE SENSITIVITY OF POORLY DIFFERENTIATED THYROID CANCER CELLS TO CHEMOTHERAPY 72
REACTIVATION OF P53 MUTANTS BY SMALL COMPOUNDS MAY REPRESENT AN ADJUVANT THERAPY OF POORLY DIFFERENTIATED THYROID CANCER 70
Levels of histone acetylation in thyroid tumors 70
Triple-negative breast cancer drug resistance, durable efficacy, and cure: how advanced biological insights and emerging drug modalities could transform progress 69
Identification of Thyroid Cancer Stem Cells 66
P63 EXPRESSION AND FUNCTION IN THYROID CANCER 64
REGULATION OF mirRNAS BY p53 FAMILIY MEMBERS IN THYROID CANCER CELLS 63
In IGF-IR deficient leiomyosarcoma cells IGF-II stimulates biological effects via the insulin receptor isoform A 57
Expanding the Clinical Profile of Mild Autonomous Cortisol Secretion: New Diagnostic Markers and Emerging Complications 11
Totale 10.254
Categoria #
all - tutte 34.394
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.394


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022400 0 0 0 7 82 3 82 29 42 0 17 138
2022/20231.252 82 43 36 155 124 182 34 230 269 24 40 33
2023/2024639 22 124 24 53 19 134 7 67 13 26 87 63
2024/20252.285 109 434 103 216 419 233 73 74 171 143 177 133
2025/20264.061 240 217 635 308 693 869 426 78 223 209 102 61
2026/2027477 134 126 38 179 0 0 0 0 0 0 0 0
Totale 10.254